Cargando…
Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles
PURPOSE: Sentinel lymph node (LN) dissection (sLND) using a magnetometer and superpara-magnetic iron oxide nanoparticles (SPION) as a tracer was successfully applied in prostate cancer (PCa). The feasibility of sentinel LN (SLN) visualization on MRI after intraprostatic SPION injection has been repo...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204856/ https://www.ncbi.nlm.nih.gov/pubmed/30425483 http://dx.doi.org/10.2147/IJN.S173182 |
_version_ | 1783366102259073024 |
---|---|
author | Winter, Alexander Kowald, Tobias Paulo, Tina Susanne Goos, Philipp Engels, Svenja Gerullis, Holger Schiffmann, Jonas Chavan, Ajay Wawroschek, Friedhelm |
author_facet | Winter, Alexander Kowald, Tobias Paulo, Tina Susanne Goos, Philipp Engels, Svenja Gerullis, Holger Schiffmann, Jonas Chavan, Ajay Wawroschek, Friedhelm |
author_sort | Winter, Alexander |
collection | PubMed |
description | PURPOSE: Sentinel lymph node (LN) dissection (sLND) using a magnetometer and superpara-magnetic iron oxide nanoparticles (SPION) as a tracer was successfully applied in prostate cancer (PCa). The feasibility of sentinel LN (SLN) visualization on MRI after intraprostatic SPION injection has been reported. In the present study, results of preoperative MRI identification of SLNs and the outcome of subsequent intraoperative magnetometer-guided sLND following intraprostatic SPION injection were studied in intermediate- and high-risk PCa. PATIENTS AND METHODS: A total of 50 intermediate- and high-risk PCa patients (prostate-specific antigen >10 ng/mL and/or Gleason score ≥7) scheduled for radical prostatectomy with magnetometer-guided sLND and extended pelvic LND (eLND), were included. Patients underwent MRI before and one day after intraprostatic SPION injection using T1-, T2-, and T2*-weighted sequences. Diagnostic rate per patient was established. Distribution of SLNs per anatomic region was registered. Diagnostic accuracy of sLND was assessed by using eLND as a reference standard. RESULTS: SPION-MRI identified a total of 890 SLNs (median 17.5; IQR 12–22.5). SLNs could be successfully detected using MRI in all patients (diagnostic rate 100%). Anatomic SLN distribution: external iliac 19.2%, common iliac 16.6%, fossa obturatoria 15.8%, internal iliac 13.8%, presacral 12.1%, perirectal 12.0%, periprostatic 3.7%, perivesical 2.3%, and other regions 4.4%. LN metastases were intraoperatively found in 15 of 50 patients (30%). sLND had a 100% diagnostic rate, 85.7% sensitivity, 97.2% specificity, 92.3% positive predictive value, 94.9% negative predictive value, false negative rate 14.3%, and 2.8% additional diagnostic value (LN metastases only outside the eLND template). CONCLUSION: MR scintigraphy after intraprostatic SPION injection provides a roadmap for intraoperative magnetometer-guided SLN detection and can be useful to characterize a reliable lymphadenectomy template. Draining LN from the prostate can be identified in an unexpectedly high number, especially outside the established eLND template. Further studies are required to analyze discordance between the number of pre- and intraoperatively identified SLNs. |
format | Online Article Text |
id | pubmed-6204856 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62048562018-11-13 Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles Winter, Alexander Kowald, Tobias Paulo, Tina Susanne Goos, Philipp Engels, Svenja Gerullis, Holger Schiffmann, Jonas Chavan, Ajay Wawroschek, Friedhelm Int J Nanomedicine Original Research PURPOSE: Sentinel lymph node (LN) dissection (sLND) using a magnetometer and superpara-magnetic iron oxide nanoparticles (SPION) as a tracer was successfully applied in prostate cancer (PCa). The feasibility of sentinel LN (SLN) visualization on MRI after intraprostatic SPION injection has been reported. In the present study, results of preoperative MRI identification of SLNs and the outcome of subsequent intraoperative magnetometer-guided sLND following intraprostatic SPION injection were studied in intermediate- and high-risk PCa. PATIENTS AND METHODS: A total of 50 intermediate- and high-risk PCa patients (prostate-specific antigen >10 ng/mL and/or Gleason score ≥7) scheduled for radical prostatectomy with magnetometer-guided sLND and extended pelvic LND (eLND), were included. Patients underwent MRI before and one day after intraprostatic SPION injection using T1-, T2-, and T2*-weighted sequences. Diagnostic rate per patient was established. Distribution of SLNs per anatomic region was registered. Diagnostic accuracy of sLND was assessed by using eLND as a reference standard. RESULTS: SPION-MRI identified a total of 890 SLNs (median 17.5; IQR 12–22.5). SLNs could be successfully detected using MRI in all patients (diagnostic rate 100%). Anatomic SLN distribution: external iliac 19.2%, common iliac 16.6%, fossa obturatoria 15.8%, internal iliac 13.8%, presacral 12.1%, perirectal 12.0%, periprostatic 3.7%, perivesical 2.3%, and other regions 4.4%. LN metastases were intraoperatively found in 15 of 50 patients (30%). sLND had a 100% diagnostic rate, 85.7% sensitivity, 97.2% specificity, 92.3% positive predictive value, 94.9% negative predictive value, false negative rate 14.3%, and 2.8% additional diagnostic value (LN metastases only outside the eLND template). CONCLUSION: MR scintigraphy after intraprostatic SPION injection provides a roadmap for intraoperative magnetometer-guided SLN detection and can be useful to characterize a reliable lymphadenectomy template. Draining LN from the prostate can be identified in an unexpectedly high number, especially outside the established eLND template. Further studies are required to analyze discordance between the number of pre- and intraoperatively identified SLNs. Dove Medical Press 2018-10-23 /pmc/articles/PMC6204856/ /pubmed/30425483 http://dx.doi.org/10.2147/IJN.S173182 Text en © 2018 Winter et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Winter, Alexander Kowald, Tobias Paulo, Tina Susanne Goos, Philipp Engels, Svenja Gerullis, Holger Schiffmann, Jonas Chavan, Ajay Wawroschek, Friedhelm Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles |
title | Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles |
title_full | Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles |
title_fullStr | Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles |
title_full_unstemmed | Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles |
title_short | Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles |
title_sort | magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204856/ https://www.ncbi.nlm.nih.gov/pubmed/30425483 http://dx.doi.org/10.2147/IJN.S173182 |
work_keys_str_mv | AT winteralexander magneticresonancesentinellymphnodeimagingandmagnetometerguidedintraoperativedetectioninprostatecancerusingsuperparamagneticironoxidenanoparticles AT kowaldtobias magneticresonancesentinellymphnodeimagingandmagnetometerguidedintraoperativedetectioninprostatecancerusingsuperparamagneticironoxidenanoparticles AT paulotinasusanne magneticresonancesentinellymphnodeimagingandmagnetometerguidedintraoperativedetectioninprostatecancerusingsuperparamagneticironoxidenanoparticles AT goosphilipp magneticresonancesentinellymphnodeimagingandmagnetometerguidedintraoperativedetectioninprostatecancerusingsuperparamagneticironoxidenanoparticles AT engelssvenja magneticresonancesentinellymphnodeimagingandmagnetometerguidedintraoperativedetectioninprostatecancerusingsuperparamagneticironoxidenanoparticles AT gerullisholger magneticresonancesentinellymphnodeimagingandmagnetometerguidedintraoperativedetectioninprostatecancerusingsuperparamagneticironoxidenanoparticles AT schiffmannjonas magneticresonancesentinellymphnodeimagingandmagnetometerguidedintraoperativedetectioninprostatecancerusingsuperparamagneticironoxidenanoparticles AT chavanajay magneticresonancesentinellymphnodeimagingandmagnetometerguidedintraoperativedetectioninprostatecancerusingsuperparamagneticironoxidenanoparticles AT wawroschekfriedhelm magneticresonancesentinellymphnodeimagingandmagnetometerguidedintraoperativedetectioninprostatecancerusingsuperparamagneticironoxidenanoparticles |